Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1991

Study Completion Date

May 31, 2003

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

aldesleukin

Trial Locations (1)

20892

Surgery Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00018941 - Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter